MA46088A - Procédés d'identification d'épitopes - Google Patents

Procédés d'identification d'épitopes

Info

Publication number
MA46088A
MA46088A MA046088A MA46088A MA46088A MA 46088 A MA46088 A MA 46088A MA 046088 A MA046088 A MA 046088A MA 46088 A MA46088 A MA 46088A MA 46088 A MA46088 A MA 46088A
Authority
MA
Morocco
Prior art keywords
identification processes
epitopic
epitopic identification
processes
identification
Prior art date
Application number
MA046088A
Other languages
English (en)
Inventor
Max Davidson
Owe Orwar
Carolina Trkulja
Original Assignee
Oblique Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oblique Therapeutics Ab filed Critical Oblique Therapeutics Ab
Publication of MA46088A publication Critical patent/MA46088A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77Internalization into the cell
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Informatics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Library & Information Science (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
MA046088A 2016-09-01 2017-09-01 Procédés d'identification d'épitopes MA46088A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614884.3A GB201614884D0 (en) 2016-09-01 2016-09-01 Method

Publications (1)

Publication Number Publication Date
MA46088A true MA46088A (fr) 2019-07-10

Family

ID=57140094

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046088A MA46088A (fr) 2016-09-01 2017-09-01 Procédés d'identification d'épitopes

Country Status (16)

Country Link
US (1) US20190194320A1 (fr)
EP (1) EP3507604A1 (fr)
JP (3) JP7032386B2 (fr)
KR (1) KR102441148B1 (fr)
CN (1) CN109791156B (fr)
AU (1) AU2017321032B2 (fr)
BR (1) BR112019004025A2 (fr)
CA (1) CA3035318A1 (fr)
GB (1) GB201614884D0 (fr)
IL (1) IL265123B2 (fr)
MA (1) MA46088A (fr)
MX (1) MX2019002455A (fr)
NZ (1) NZ752191A (fr)
RU (1) RU2771584C2 (fr)
SG (1) SG11201901603RA (fr)
WO (1) WO2018042010A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3765856B1 (fr) * 2018-03-13 2023-09-27 Amgen Inc. Procédés de préparation de polypeptides résistant à la trypsine pour analyse par spectrométrie de masse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2303264C2 (ru) * 2001-02-19 2007-07-20 Мерк Патент Гмбх Способ идентификации эпитопов т-клеток и его применение для получения молекул со сниженной иммуногенностью
GEP20196963B (en) * 2003-07-15 2019-04-10 Inc Amgen Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
MA41842A (fr) * 2015-03-31 2018-02-06 Oblique Therapeutics Ab Nouveaux procédés de sélection d'épitope

Also Published As

Publication number Publication date
IL265123B2 (en) 2024-08-01
JP2019536427A (ja) 2019-12-19
WO2018042010A1 (fr) 2018-03-08
SG11201901603RA (en) 2019-03-28
KR20190045252A (ko) 2019-05-02
NZ752191A (en) 2023-03-31
AU2017321032A1 (en) 2019-04-18
CN109791156A (zh) 2019-05-21
JP2022033845A (ja) 2022-03-02
JP2024037751A (ja) 2024-03-19
GB201614884D0 (en) 2016-10-19
JP7032386B2 (ja) 2022-03-08
KR102441148B1 (ko) 2022-09-06
BR112019004025A2 (pt) 2019-08-20
CN109791156B (zh) 2022-11-22
CA3035318A1 (fr) 2018-03-08
US20190194320A1 (en) 2019-06-27
RU2771584C2 (ru) 2022-05-06
IL265123B1 (en) 2024-04-01
IL265123A (fr) 2024-04-01
EP3507604A1 (fr) 2019-07-10
AU2017321032B2 (en) 2024-05-30
RU2019105088A3 (fr) 2020-12-21
RU2019105088A (ru) 2020-10-01
MX2019002455A (es) 2019-05-30

Similar Documents

Publication Publication Date Title
MA55748A (fr) Procédés de détection d'aav
FR3036037B1 (fr) Harnais d'encordement perfectionne
MA41296A (fr) Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
MA41298A (fr) Procédés de marquage de banques codées par de l'adn
MA48596A (fr) Caractéristique d'inertie
MA41842A (fr) Nouveaux procédés de sélection d'épitope
MA44972A (fr) Procédés d'identification de modulateurs du cftr
FR3038247B1 (fr) Machine d'etirage de film
DK3299718T3 (da) Gasartidentificering
MA46088A (fr) Procédés d'identification d'épitopes
FR3037692B1 (fr) Procede d'identification biometrique
FR3022662B1 (fr) Dispositif d'identification biometrique
ES1109830Y (es) " senalador de prendas"
ES1201085Y (es) Cinta identificativa
ITUA20163609A1 (it) "micro-cogeneratore".
ITUA20162131A1 (it) Fibbia migliorata
ITUA20163709A1 (it) "presentosa3d"
IT201700090331A1 (it) "lopemide"
IT201700071679A1 (it) Remembebe'
FR3035249B1 (fr) Dispositif d'identification d'objet
UA34848S (uk) Етикетка «супофф»
UA34650S (uk) Етикетка «канів 1971»
ITUA20161486A1 (it) Capo d'abbigliamento
ITUA20162584A1 (it) Capo d'abbigliamento.
UA34704S (uk) Етикетка «велес»